BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9486675)

  • 1. The spectrum of cutaneous reactions associated with diltiazem: three cases and a review of the literature.
    Knowles S; Gupta AK; Shear NH
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):201-6. PubMed ID: 9486675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers.
    Gonzalo Garijo MA; Pérez Calderón R; de Argila Fernández-Durán D; Rangel Mayoral JF
    Allergol Immunopathol (Madr); 2005; 33(4):238-40. PubMed ID: 16045866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adverse reactions associated with calcium channel blockers.
    Stern R; Khalsa JH
    Arch Intern Med; 1989 Apr; 149(4):829-32. PubMed ID: 2523214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drugs associated with acute generalized exanthematic pustulosis].
    Saissi EH; Beau-Salinas F; Jonville-Béra AP; Lorette G; Autret-Leca E;
    Ann Dermatol Venereol; 2003; 130(6-7):612-8. PubMed ID: 13679697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross reactions between calcium channel blockers.
    Cholez C; Trechot P; Schmutz JL; Faure G; Bene MC; Barbaud A
    Allergy; 2003 Nov; 58(11):1207-9. PubMed ID: 14616146
    [No Abstract]   [Full Text] [Related]  

  • 6. Diltiazem-induced acute generalised exanthematous pustulosis.
    Wakelin SH; James MP
    Clin Exp Dermatol; 1995 Jul; 20(4):341-4. PubMed ID: 8548996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous adverse reactions to calcium channel blockers.
    Tuchinda P; Kulthanan K; Khankham S; Jongjarearnprasert K; Dhana N
    Asian Pac J Allergy Immunol; 2014 Sep; 32(3):246-50. PubMed ID: 25268343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis induced by diltiazem: value of patch testing.
    Jan V; Machet L; Gironet N; Martin L; Machet MC; Lorette G; Vaillant L
    Dermatology; 1998; 197(3):274-5. PubMed ID: 9867362
    [No Abstract]   [Full Text] [Related]  

  • 9. Exfoliative dermatitis associated with diltiazem.
    Odeh M
    J Toxicol Clin Toxicol; 1997; 35(1):101-4. PubMed ID: 9022661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute generalized exanthematous pustulosis due to diltiazem: Investigation of cross-reactivity with other calcium channel blockers.
    Sáenz de Santa María García M; Noguerado-Mellado B; Rojas Pérez-Ezquerra P; Hernandez-Aragües I; De Barrio Fernández M
    J Allergy Clin Immunol Pract; 2016; 4(4):765-6. PubMed ID: 27025295
    [No Abstract]   [Full Text] [Related]  

  • 11. Diltiazem and subacute cutaneous lupus erythematosus-like lesions.
    Crowson AN; Magro CM
    N Engl J Med; 1995 Nov; 333(21):1429. PubMed ID: 7477141
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous reactions induced by calcium channel blocker: high frequency of psoriasiform eruptions.
    Kitamura K; Kanasashi M; Suga C; Saito S; Yoshida S; Ikezawa Z
    J Dermatol; 1993 May; 20(5):279-86. PubMed ID: 8340532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute generalised exanthematosus pustulosis (AGEP) due to diltiazem--a case report].
    Barcik K; Protas-Drozd F; Weiss-Rostkowska W; Flis E; Placek W
    Kardiol Pol; 2009 Aug; 67(8):887-91. PubMed ID: 19784887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Photodistributed reticulated hyperpigmentation related to diltiazem.
    Jaka A; López-Pestaña A; Tuneu A; Lobo C; López-Núñez M; Ormaechea N
    Dermatol Online J; 2011 Jul; 17(7):14. PubMed ID: 21810399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR).
    Sidoroff A; Dunant A; Viboud C; Halevy S; Bavinck JN; Naldi L; Mockenhaupt M; Fagot JP; Roujeau JC
    Br J Dermatol; 2007 Nov; 157(5):989-96. PubMed ID: 17854366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem-induced drug eruption sparing seborrheic keratoses.
    Heymann WR
    Cutis; 2000 Aug; 66(2):129-30. PubMed ID: 10955194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic allergic dermatitis caused by diltiazem.
    Opstrup MS; Guldager S; Zachariae C; Thyssen JP
    Contact Dermatitis; 2017 Jun; 76(6):364-365. PubMed ID: 28497625
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis.
    Girardi M; Duncan KO; Tigelaar RE; Imaeda S; Watsky KL; McNiff JM
    Am J Dermatopathol; 2005 Aug; 27(4):343-6. PubMed ID: 16121058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial hyperpigmentation caused by diltiazem hydrochloride.
    Desai N; Alexis AF; DeLeo VA
    Cutis; 2010 Aug; 86(2):82-4. PubMed ID: 20919601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact allergy to diltiazem cream.
    Leinonen PT; Riekki R; Oikarinen A
    Contact Dermatitis; 2010 Oct; 63(4):228-30. PubMed ID: 20831689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.